Evidence map›Paper›PMID 36040111›Full record

ArticleJournal of hospital medicine2022

Variation in the risk of death due to COVID-19: An international multicenter cohort study of hospitalized adults.

Kieran L Quinn, Husam Abdel-Qadir, Kali Barrett, Emily Bartsch, Andrea Beaman, Tor Biering-Sørensen, Michael Colacci, Alex Cressman, Allan Detsky, Alexi Gosset and 16 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of hospital medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 10 institutions in 3 countries.

Kieran L QuinnDepartment of Medicine, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-1681-5170
Husam Abdel-QadirDepartment of Medicine, Division of Cardiology, Women's College Hospital, Toronto, Ontario, Canada.ORCID 0000-0002-7105-7931
Kali BarrettDepartment of Medicine, University Health Network, Toronto, Ontario, Canada.
Emily BartschDepartment of Medicine, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
Andrea BeamanDepartment of Pharmacy, Trillium Health Partners, Mississauga, Ontario, Canada.
Tor Biering-SørensenDepartment of Cardiology, University of Copenhagen, Copenhagen, Denmark.
Michael ColacciDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Alex CressmanDivision of Internal Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Allan DetskyDepartment of Medicine, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.
Alexi GossetDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Mats H LassenDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Chris KandelDepartment of Medicine, Michael Garron Hospital, Toronto, Ontario, Canada.ORCID 0000-0003-1256-309X
Yaariv KhaykinDepartment of Medicine, Southlake Regional Health Centre, Newmarket, Ontario, Canada.
Lauren Lapointe-ShawDepartment of Medicine, University Health Network, Toronto, Ontario, Canada.ORCID 0000-0003-4485-6719
Erik LovblomDepartment of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Derek R MacFaddenDepartment of Medicine, The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
Bruce PerkinsDepartment of Medicine, University Health Network, Toronto, Ontario, Canada.
Kenneth J RothmanDepartment of Epidemiology, School of Public Health, Boston University, Massachusetts, Boston, USA.
Kristoffer G SkaarupDepartment of Pharmacy, Trillium Health Partners, Mississauga, Ontario, Canada.
Nathan StallDepartment of Medicine, Division of General Internal Medicine and Geriatrics, Sinai Health and the University Health Network, Toronto, Ontario, Canada.
Terence TangDepartment of Medicine, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-1735-7298
Chris YarnellDepartment of Medicine, Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.
Jonathan ZipurskyDepartment of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Matthew T WarkentinDepartment of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Mike FralickDepartment of Medicine, Sinai Health System, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0002-2082-2445
COVID-ACE Group
University of Toronto · CAUniversity Health Network · CAMount Sinai Hospital · CATrillium Health Centre · CABoston University · USOttawa Hospital · CASouthlake Regional Health Center · CASunnybrook Health Science Centre · CAToronto East General Hospital · CAUniversity of Copenhagen · DK

Funding

Department of Medicine, University of Toronto
6 · The paper itself

Abstract

backgroundThere is wide variation in mortality among patients hospitalized with COVID-19. Whether this is related to patient or hospital factors is unknown.

objectiveTo compare the risk of mortality for patients hospitalized with COVID-19 and to determine whether the majority of that variation was explained by differences in patient characteristics across sites. DESIGN, SETTING, AND

participantsAn international multicenter cohort study of hospitalized adults with laboratory-confirmed COVID-19 enrolled from 10 hospitals in Ontario, Canada and 8 hospitals in Copenhagen, Denmark between January 1, 2020 and November 11, 2020. MAIN OUTCOMES AND MEASURES: Inpatient mortality. We used a multivariable multilevel regression model to compare the in-hospital mortality risk across hospitals and quantify the variation attributable to patient-level factors.

resultsThere were 1364 adults hospitalized with COVID-19 in Ontario (n = 1149) and in Denmark (n = 215). In Ontario, the absolute risk of in-hospital mortality ranged from 12.0% to 39.8% across hospitals. Ninety-eight percent of the variation in mortality in Ontario was explained by differences in the characteristics of the patients. In Denmark, the absolute risk of inpatients ranged from 13.8% to 20.6%. One hundred percent of the variation in mortality in Denmark was explained by differences in the characteristics of the inpatients.

conclusionThere was wide variation in inpatient COVID-19 mortality across hospitals, which was largely explained by patient-level factors, such as age and severity of presenting illness. However, hospital-level factors that could have affected care, including resource availability and capacity, were not taken into account. These findings highlight potential limitations in comparing crude mortality rates across hospitals for the purposes of reporting on the quality of care.

Indexed as

COVID-19AdultCohort StudiesHospitalizationHospital MortalityHumansOntario

Identifiers

PMID36040111
PMCPMC9539016
OpenAlexW4293569046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.